Skip to content
10-K

Annual Report

Targeted Medical Pharma, Inc.

0001493152-16-008933

← back to feed
Filed
Apr 14, 2016 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2015 · Apr 13, 2016 30.19M sh
Operating Cash Flow FY 2015 · Dec 31, 2015 −$1.28M
Operating Cash Flow FY 2015 · Dec 31, 2014 $780.31K
Cash And Equivalents FY 2015 · Dec 31, 2015 $82.64K
Cash And Equivalents FY 2015 · Dec 31, 2014 $11.74K
Cash And Equivalents FY 2015 · Dec 31, 2013 $491.81K
Stockholders Equity FY 2015 · Dec 31, 2015 −$12.9M
Stockholders Equity FY 2015 · Dec 31, 2014 −$9.97M
Stockholders Equity FY 2015 · Dec 31, 2013 −$7.02M
Current Liabilities FY 2015 · Dec 31, 2015 $14.68M
Current Liabilities FY 2015 · Dec 31, 2014 $12.35M
Total Liabilities FY 2015 · Dec 31, 2015 $15.35M
Total Liabilities FY 2015 · Dec 31, 2014 $12.47M
Current Assets FY 2015 · Dec 31, 2015 $832.99K
Current Assets FY 2015 · Dec 31, 2014 $533.96K
Total Assets FY 2015 · Dec 31, 2015 $2.43M
Total Assets FY 2015 · Dec 31, 2014 $2.5M
Sga Expense FY 2015 · Dec 31, 2015 $5.18M
Sga Expense FY 2015 · Dec 31, 2014 $7.35M
Rd Expense FY 2015 · Dec 31, 2015 $12.32K
Rd Expense FY 2015 · Dec 31, 2014 $158.37K
Net Income FY 2015 · Dec 31, 2015 −$3.04M
Net Income FY 2015 · Dec 31, 2014 −$3.9M
Operating Income FY 2015 · Dec 31, 2015 −$2.03M
Operating Income FY 2015 · Dec 31, 2014 −$2.61M
Gross Profit FY 2015 · Dec 31, 2015 $3.17M
Gross Profit FY 2015 · Dec 31, 2014 $4.9M
Cost Of Revenue FY 2015 · Dec 31, 2015 $2.1M
Cost Of Revenue FY 2015 · Dec 31, 2014 $2.22M
Revenue FY 2015 · Dec 31, 2015 $5.26M
Revenue FY 2015 · Dec 31, 2014 $7.11M